1. Home
  2. MNKD vs EXK Comparison

MNKD vs EXK Comparison

Compare MNKD & EXK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • EXK
  • Stock Information
  • Founded
  • MNKD 1991
  • EXK 1981
  • Country
  • MNKD United States
  • EXK Canada
  • Employees
  • MNKD N/A
  • EXK N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • EXK Precious Metals
  • Sector
  • MNKD Health Care
  • EXK Basic Materials
  • Exchange
  • MNKD Nasdaq
  • EXK Nasdaq
  • Market Cap
  • MNKD 1.4B
  • EXK 1.2B
  • IPO Year
  • MNKD 2004
  • EXK N/A
  • Fundamental
  • Price
  • MNKD $4.56
  • EXK $3.56
  • Analyst Decision
  • MNKD Buy
  • EXK Strong Buy
  • Analyst Count
  • MNKD 6
  • EXK 3
  • Target Price
  • MNKD $8.92
  • EXK $6.83
  • AVG Volume (30 Days)
  • MNKD 1.5M
  • EXK 12.0M
  • Earning Date
  • MNKD 05-08-2025
  • EXK 05-13-2025
  • Dividend Yield
  • MNKD N/A
  • EXK N/A
  • EPS Growth
  • MNKD 215.86
  • EXK N/A
  • EPS
  • MNKD 0.10
  • EXK N/A
  • Revenue
  • MNKD $297,595,000.00
  • EXK $217,639,000.00
  • Revenue This Year
  • MNKD $14.23
  • EXK $97.24
  • Revenue Next Year
  • MNKD $14.56
  • EXK $50.33
  • P/E Ratio
  • MNKD $46.04
  • EXK N/A
  • Revenue Growth
  • MNKD 32.50
  • EXK 5.93
  • 52 Week Low
  • MNKD $4.17
  • EXK $2.46
  • 52 Week High
  • MNKD $7.63
  • EXK $5.67
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 38.80
  • EXK 46.23
  • Support Level
  • MNKD $4.42
  • EXK $3.35
  • Resistance Level
  • MNKD $5.05
  • EXK $3.67
  • Average True Range (ATR)
  • MNKD 0.18
  • EXK 0.18
  • MACD
  • MNKD 0.00
  • EXK -0.00
  • Stochastic Oscillator
  • MNKD 20.59
  • EXK 45.65

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About EXK Endeavour Silver Corporation (Canada)

Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has two operating mining segments which are located in Mexico, Guanacevi and Bolanitos. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.

Share on Social Networks: